Samsung's biotech unit debuts in Seoul. Here's what to know.

·

·

Samsung's biotech unit debuts in Seoul. Here's what to know.

SEOUL, South Korea (AP) – Samsung Biologics Co., the contract drug making unit of Samsung Group, made its market debut in Seoul on Thursday in South Korea's largest initial public offering in six years.
See Original Article

FRS 102: acquisition accounting obligations

Under FRS 102, many privately-owned acquiring companies are required to apply a purchase method of accounting broadly in line with International
See Original Article

Asian Shares Rally With European Futures, Metals on Trump Bets

The Bloomberg Dollar Spot Index slipped 0.2 percent after rallying 1.4 percent on Wednesday. The implied probability of a December Fed hike, which
See Original Article

China Oct vehicle sales up 18.7 pct y/y -industry body

BEIJING, Nov 10 (Reuters) – Auto sales in China rose 18.7 percent to 2.7 million vehicles in October from a year earlier, slowing slightly from September to end a five-month streak of strengthening sales, the China Association of Automobile …
See Original Article

Trump's Win May Be Asia's Loss

Just when China's economy seemed to be stabilizing, Donald Trump's election as U.S. president poses significant new risks. Not just for Chinese
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.